Search - tctmd.com

Displaying 361 - 380 of 380

Sort: Relevancy | Date

News Daily News

No hay una Ventana Segura para la Terapia Antitrombótica Triple en Pacientes con FA de Alto Riesgo

August 14, 2012

News Daily News

Indirect Comparisons Show Little Difference Among New Anticoagulants

August 14, 2012

News Daily News

Comparativas Indirectas revelan que hay Pocas Diferencias entre Nuevos Anticoagulantes

August 14, 2012

Presentation

Bleeding After Initiation of Multiple Antithrombotic Drugs, Including Triple Therapy, in A-fib Patients Following MI and PCI

Presenter: M. Lamberts

August 10, 2012

News Daily News

Updated Guidelines Support New Antithrombotics as Warfarin Alternatives in A-fib

L.A. McKeown

August 09, 2012

News Daily News

Las Directrices Actualizadas Avalan los Nuevos Antitrombóticos como Alternativas a la Warfarina contra la FA

L.A. McKeown

August 09, 2012

News Daily News

La Anticoagulación Protege a aquellos Pacientes con FA que se someten a PCI, a pesar del Riesgo Hemorrágico

Caitlin E. Cox

July 16, 2012

News Daily News

Anticoagulation Protects A-Fib Patients Undergoing PCI, Despite Bleeding Risk

Caitlin E. Cox

July 16, 2012

News Daily News

CHARISMA Genetics Analysis: CYP2C19 Variants Show Little Clinical Impact

April 10, 2012

News Conference News ACC 2012

New Antiplatelet Agent Vorapaxar Shows Promise, But At the Expense of Bleeding

L.A. McKeown

March 24, 2012

News Daily News

Better Clopidogrel Response Seen with Increased Smoking Levels

Jason Kahn

March 21, 2012

News Daily News

First-Year Stent Thombosis Risk High—and Dangerous—in ACS Patients

October 31, 2011

News Daily News

ROCKET AF Published: Rivaroxaban Matches Warfarin in Treating A-Fib Patients

Caitlin E. Cox

August 10, 2011

News Daily News

Ticagrelor Gains FDA Approval for Use in ACS

Caitlin E. Cox

July 22, 2011

News Daily News

HORIZONS-AMI: Bivalirudin Reduces Cardiac Death in Diabetics

Jason Kahn

July 18, 2011

News Daily News

Adding Omega-3 Fatty Acids to Dual Antiplatelet Therapy May Reduce Thrombotic Risk

Leah Lawrence

May 26, 2011

News Daily News

Elderly STEMI Patients Face Poorer Outcomes After Primary PCI

Caitlin E. Cox

April 20, 2011

News Daily News

In Vivo Study Suggests DES Polymer-Drug Coatings Not Inherently Thrombogenic

Caitlin E. Cox

March 25, 2011

News Daily News

Early Morning Circadian Rhythms Linked to Stent Thrombosis

February 21, 2011

News Daily News

New Anticoagulant More Effective Than Aspirin at Stroke Prevention in A-fib

Jason Kahn

February 09, 2011

Advertisement

No hay una Ventana Segura para la Terapia Antitrombótica Triple en Pacientes con FA de Alto Riesgo

Indirect Comparisons Show Little Difference Among New Anticoagulants

Comparativas Indirectas revelan que hay Pocas Diferencias entre Nuevos Anticoagulantes

Bleeding After Initiation of Multiple Antithrombotic Drugs, Including Triple Therapy, in A-fib Patients Following MI and PCI

Updated Guidelines Support New Antithrombotics as Warfarin Alternatives in A-fib

Las Directrices Actualizadas Avalan los Nuevos Antitrombóticos como Alternativas a la Warfarina contra la FA

La Anticoagulación Protege a aquellos Pacientes con FA que se someten a PCI, a pesar del Riesgo Hemorrágico

Anticoagulation Protects A-Fib Patients Undergoing PCI, Despite Bleeding Risk

CHARISMA Genetics Analysis: CYP2C19 Variants Show Little Clinical Impact

New Antiplatelet Agent Vorapaxar Shows Promise, But At the Expense of Bleeding

Better Clopidogrel Response Seen with Increased Smoking Levels

First-Year Stent Thombosis Risk High—and Dangerous—in ACS Patients

ROCKET AF Published: Rivaroxaban Matches Warfarin in Treating A-Fib Patients

Ticagrelor Gains FDA Approval for Use in ACS

HORIZONS-AMI: Bivalirudin Reduces Cardiac Death in Diabetics

Adding Omega-3 Fatty Acids to Dual Antiplatelet Therapy May Reduce Thrombotic Risk

Elderly STEMI Patients Face Poorer Outcomes After Primary PCI

In Vivo Study Suggests DES Polymer-Drug Coatings Not Inherently Thrombogenic

Early Morning Circadian Rhythms Linked to Stent Thrombosis

New Anticoagulant More Effective Than Aspirin at Stroke Prevention in A-fib

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content